Varicose Veins Treatment Market Size

  • Report ID: 4936
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Varicose Veins Treatment Market Size

Varicose Veins Treatment Market size was valued at USD 1.21 billion in 2024 and is expected to cross USD 4.12 billion by the end of 2037, expanding at more than 9.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of varicose veins treatment is estimated at USD 1.31 billion.

The market growth can be attributed to the increasing number of elderly people who are prone to different types of varicose veins. Further, the growing prevalence of R&D activities in the field of compression and newer technologies for the treatment of varicose veins across the globe will add to the market expansion.

Additionally, soaring investments and collaboration between major industry players to discover effective treatments for varicose veins will boost the market demand. For instance, on October 2021, the FDA granted a 510k clearance to VenClose Inc., a privately owned Silicon Valley medical device company focused on innovative treatments for venous reflux diseases through novel catheters of radiofrequency ablation known as MavenRFA that can be minimally invasive in treating hypo perforator vein.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4936
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of varicose veins treatment is estimated at USD 1.31 billion.

The varicose veins treatment market size was valued at USD 1.21 billion in 2024 and is expected to cross USD 4.12 billion by the end of 2037, expanding at more than 9.8% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by increasing varicose vein global burden, and surging preference for minimally invasive treatment procedures.

North America industry share is predicted to cross 34% by 2037, due to increasing number of well-developed healthcare systems in the region.

The major players in the market include Candela Medical, Medtronic PLC, Boston Scientific, El. En SpA Group, Teleflex Incorporated, Eufoton SRL, Biolitec AG (BioMed Technology Holdings Ltd), AngioDynamics Inc., Alma Lasers Ltd, Sciton Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample